Skip to content

Category Archives: Complete clinical development

V.C.s lead Spin-Off of Boston Scientific Unit > TriVascular2 > Divest nonstrategic assets > $65 million from previous and new investors > Series A preferred round to finance spinout > Programs Boston Scientific suspended in June 2006 > MPM Capital > New Enterprise Associates > Delphi Ventures > Kearny Venture Partners > Complete clinical development > Endovascular aneurysm repair EVAR > Stent-graft

Does TriVascular address an opportunity that justifies the new investments by MPM Capital and NEA? Is it feasible to address a broader patient population requiring endovascular repair of aortic aneurysms with the novel stent-graft from TriVascular? Will these patients have a safe and permanent alternative to open surgical repair?

IIP > Read on here…
TriVascular2, a company […]